Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1420542838;42839;42840 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
N2AB1256437915;37916;37917 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
N2A1163735134;35135;35136 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
N2B514015643;15644;15645 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
Novex-1526516018;16019;16020 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
Novex-2533216219;16220;16221 chr2:178633886;178633885;178633884chr2:179498613;179498612;179498611
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: TTG
  • RefSeq wild type template codon: AAC
  • Domain: Ig-92
  • Domain position: 64
  • Structural Position: 146
  • Q(SASA): 0.7873
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/V rs747480084 -0.353 0.201 N 0.385 0.046 0.293147016451 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.9E-06 0
L/V rs747480084 -0.353 0.201 N 0.385 0.046 0.293147016451 gnomAD-4.0.0 1.36869E-06 None None None None N None 0 0 None 0 0 None 0 0 1.79921E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.4922 ambiguous 0.3949 ambiguous -0.902 Destabilizing 0.25 N 0.376 neutral None None None None N
L/C 0.8765 likely_pathogenic 0.8162 pathogenic -0.654 Destabilizing 0.982 D 0.419 neutral None None None None N
L/D 0.9286 likely_pathogenic 0.8948 pathogenic -0.371 Destabilizing 0.7 D 0.547 neutral None None None None N
L/E 0.6681 likely_pathogenic 0.6325 pathogenic -0.452 Destabilizing 0.7 D 0.557 neutral None None None None N
L/F 0.4189 ambiguous 0.3321 benign -0.809 Destabilizing 0.638 D 0.319 neutral N 0.468877891 None None N
L/G 0.8328 likely_pathogenic 0.7627 pathogenic -1.099 Destabilizing 0.7 D 0.553 neutral None None None None N
L/H 0.6354 likely_pathogenic 0.5355 ambiguous -0.325 Destabilizing 0.982 D 0.564 neutral None None None None N
L/I 0.1762 likely_benign 0.1392 benign -0.491 Destabilizing 0.25 N 0.356 neutral None None None None N
L/K 0.4073 ambiguous 0.3724 ambiguous -0.536 Destabilizing 0.7 D 0.445 neutral None None None None N
L/M 0.2156 likely_benign 0.157 benign -0.449 Destabilizing 0.015 N 0.233 neutral N 0.470275751 None None N
L/N 0.7688 likely_pathogenic 0.6864 pathogenic -0.307 Destabilizing 0.826 D 0.558 neutral None None None None N
L/P 0.6021 likely_pathogenic 0.5015 ambiguous -0.594 Destabilizing 0.005 N 0.373 neutral None None None None N
L/Q 0.4104 ambiguous 0.3484 ambiguous -0.547 Destabilizing 0.7 D 0.478 neutral None None None None N
L/R 0.3698 ambiguous 0.3486 ambiguous 0.074 Stabilizing 0.7 D 0.475 neutral None None None None N
L/S 0.6631 likely_pathogenic 0.5089 ambiguous -0.79 Destabilizing 0.638 D 0.397 neutral N 0.440615593 None None N
L/T 0.4728 ambiguous 0.364 ambiguous -0.76 Destabilizing 0.7 D 0.302 neutral None None None None N
L/V 0.1955 likely_benign 0.1606 benign -0.594 Destabilizing 0.201 N 0.385 neutral N 0.440072812 None None N
L/W 0.6044 likely_pathogenic 0.4919 ambiguous -0.813 Destabilizing 0.976 D 0.549 neutral D 0.593583172 None None N
L/Y 0.7616 likely_pathogenic 0.6775 pathogenic -0.579 Destabilizing 0.826 D 0.379 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.